2011~2020年我国生物医学领域科技成果转化分析

doi:10.13523/j.cb.2111046

中国生物工程杂志

2022, Vol. 42

Issue (1/2): 191-201 DOI: 10.13523/j.cb.2111046

专利

2011~2020年我国生物医学领域科技成果转化分析

吴东¹,肖枫²,袁敏²,陈禹保^3,^*(

),张宏翔^4,^*(

)

1 中国医学科学院北京协和医院北京 100730
2 北京预立生科知识产权代理有限公司北京 100176
3 中国医学科学院医学实验动物研究所北京 100083
4 中国科学院文献情报中心北京 100190

Transformation of Scientific and Technological Achievements in Biomedical Field in China from 2011 to 2020

WU Dong¹,XIAO Feng²,YUAN Min²,CHEN Yu-bao^3,^*(

),ZHANG Hong-xiang^4,^*(

)

1 Peking Union Medical College Hospital,Chinese Academy of Medical Sciences, Beijing 100730, China
2 Beijing Preintellip Intellectual property Agency Co. LTD, Beijing 100176, China
3 Institute of Laboratory Animal Sciences,CAMS&PUMC, Beijing 100083, China
4 National Science Library, Chinese Academy of Sciences, Beijing 100190, China

全文: PDF(4111 KB) HTML

摘要：

基于国内转让/许可专利库数据,全面系统地对我国生物医学领域专利成果转化进行梳理分析。研究表明,虽然目前我国生物医学专利转化率偏低,且部分领域转化明显滞后,但在2015年国家修订《促进科技成果转化法》后,各方积极探索成果转化新模式,转化成绩显著,转化的技术趋势也与生物医学产业发展趋势基本符合,表明政策有效驱动转化工作开展。建议相关部门继续完善政策,建立转化生态圈,并在疫情防控中发挥生物医学专利成果转化更大作用。

关键词： 成果转化; 专利; 生物医学; 新冠肺炎疫情

Abstract:

Based on the data of domestic patent transfer/license database, this paper systematically combs and analyzes the transformation of biomedical patent achievements in China. The research shows that although the conversion rate of biomedical patents in China is low at present, and the transformation in some fields lags behind obviously, after the revision of the Law of Promoting the Transformation of Scientific and Technological Achievements in 2015, all parties actively explore a new mode of transformation of achievements, and the transformation technology trend is basically consistent with the development trend of biomedical industry, indicating that the policy effectively drives the transformation work. It is suggested that relevant departments continue to improve policies, establish a transformation ecosystem, and play a greater role in the transformation of biomedical patent achievements in epidemic prevention and control.

Key words: Achievements transformation Patent Biomedicine COVID-19

收稿日期: 2021-11-23 出版日期: 2022-03-03

ZTFLH:

Q819

通讯作者: 陈禹保,张宏翔 E-mail: longf04@163.com;zhanghx@mail.las.ac.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	吴东
	肖枫
	袁敏
	陈禹保
	张宏翔

引用本文:

吴东,肖枫,袁敏,陈禹保,张宏翔. 2011~2020年我国生物医学领域科技成果转化分析[J]. 中国生物工程杂志, 2022, 42(1/2): 191-201.

WU Dong,XIAO Feng,YUAN Min,CHEN Yu-bao,ZHANG Hong-xiang. Transformation of Scientific and Technological Achievements in Biomedical Field in China from 2011 to 2020. China Biotechnology, 2022, 42(1/2): 191-201.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2111046 或 https://manu60.magtech.com.cn/biotech/CN/Y2022/V42/I1/2/191

图1 2011~2020年生物医学领域专利转化的时间趋势

图2 2011~2020年生物医学领域发生转化的专利类型分布情况

表1 2011~2020年生物医学领域转化专利的所在技术领域

表2 生物医学各技术领域2011~2015年与2016~2020年转化情况

图3 2011~2020年生物医学领域专利转化活跃度排名前10的省市

图4 2011~2020年生物医学领域专利转化排名前10的转化主体

图5 2011~2020年生物医学领域专利转化排名前10的需求主体

图6 2011~2020年生物医学领域转化专利的失效原因

图7 2011~2020年生物医学领域专利转化后的维持时间及失效专利数

表3 失效专利中排名前10的主分类号

[1]	Wang Y D, Huang J S, Chen Y T, et al. Have Chinese universities embraced their third mission? new insight from a business perspective. Scientometrics, 2013, 97(2):207-222. doi: 10.1007/s11192-013-1055-z
[2]	施晴, 王芸, 徐宏, 等. 基于专利转化的高校生物医药专利质量评价研究. 科技管理研究, 2019, 39(11):139-145.
	Shi Q, Wang Y, Xu H, et al. Quality evaluation of biomedical patents based on colleges and universities patent transformation. Science and Technology Management Research, 2019, 39(11):139-145.
[3]	林琪云, 米学娇. 浅析发明专利高数量与低转化率的矛盾:以国家知识产权战略实施五年为视角. 现代商业, 2014(14):66-68.
	Lin Q Y, Mi X J. Analysis of the contradiction between the high number of invention patents and the low conversion rate: from the perspective of the five-year implementation of the national intellectual property strategy. Modern Business, 2014(14):66-68.
[4]	刘子晨. 专利权评价报告制度研究. 青岛: 青岛大学, 2018.
	Liu Z C. Research on patent evaluation report system. Qingdao: Qingdao University, 2018.
[5]	杨山石, 金春林, 黄玉捷, 等. 国内外医药及医疗器械领域专利技术差异分析. 中国卫生资源, 2020, 23(3):206-210.
	Yang S S, Jin C L, Huang Y J, et al. Comparison on patent technology differences in fields of medicine and medical devices at home and abroad. Chinese Health Resources, 2020, 23(3):206-210.
[6]	李树祥, 褚淑贞, 杨庆, 等. 江苏省生物医药专利合作网络演化特征分析. 科技管理研究, 2021, 41(2):181-186.
	Li S X, Chu S Z, Yang Q, et al. Analysis on evolution characteristics of biomedicine patent cooperation network in Jiangsu Province. Science and Technology Management Research, 2021, 41(2):181-186.
[7]	McAdam R, Miller K, McAdam M, et al. The development of university technology transfer stakeholder relationships at a regional level: lessons for the future. Technovation, 2012, 32(1):57-67. doi: 10.1016/j.technovation.2011.08.001
[8]	Mêgnigbêto E. Triple Helix of university-industry-government relationships in West Africa. Journal of Scientometric Research, 2013, 2:214-222. doi: 10.4103/2320-0057.135413
[9]	Hershberg E, Nabeshima K, Yusuf S. Opening the Ivory tower to business: university-industry linkages and the development of knowledge-intensive clusters in Asian cities. World Development, 2007, 35(6):931-940. doi: 10.1016/j.worlddev.2006.05.006
[10]	刘扬, 李海燕, 肖宇锋. 国际中药失效专利分析. 中草药, 2015, 46(22):3441-3446.
	Liu Y, Li H Y, Xiao Y F. Analysis on international invalid patents of Chinese materia medica. Chinese Traditional and Herbal Drugs, 2015, 46(22):3441-3446.
[11]	跨越“死亡之谷”:生物产业从实验室到市场要过几道关. 中国战略新兴产业, 2014(14):30-31.
	Crossing the “Valley of Death”:How many barriers does the bioindustry have to pass from the laboratory to the market? China Strategic Emerging Industry, 2014(14):30-31.
[12]	陈冰. 上海创新是如何赢得世界认可的? 新民周刊, 2017(40):78-83.
	Chen B. How does Shanghai innovation win world recognition? Xinmin Weekly, 2017(40):78-83.
[13]	Sun Y T, Zhang C, Kok R A W. The role of research outcome quality in the relationship between university research collaboration and technology transfer: empirical results from China. Scientometrics, 2020, 122(2):1003-1026. doi: 10.1007/s11192-019-03330-6
[14]	教育部, 国家知识产权局, 科技部. 教育部国家知识产权局科技部关于提升高等学校专利质量促进转化运用的若干意见. 科学中国人, 2020(S2):78-83.
	Ministry of Education of the People’s Republic of China, China National Intellectual Property Administration, Ministry of Science and Technology of the People’s Republic of China. Ministry of Education of the People’s Republic of China, China National Intellectual Property Administration, Ministry of Science and Technology of the People’s Republic of China on improving the quality of patent in colleges and universities and promoting the transformation and utilization (Jiao Ke Ji (2020) No.1). Scientific Chinese, 2020(S5):78-83.
[15]	国家卫生计生委, 科学技术部, 国家食品药品监督管理总局, 等. 关于加强卫生与健康科技成果转移转化工作的指导意见. 中华人民共和国国家卫生和计划生育委员会公报, 2016(10):16-21.
	National Health and Family Planning Commission, Ministry of Science and Technology of the People’s Republic of China, China Food and Drug Administration, et al. Guidelines on strengthening the technological achievements transformation in health and hygiene. Gazette of the National Health and Family Planning Commission of People’s Republic of China, 2016(10):16-21.
[16]	王玮. 浅析我国的药品专利期限补偿制度. 中国医药工业杂志, 2021, 52(1):143-146.
	Wang W. Discussion on the system of drug patent term compensation. Chinese Journal of Pharmaceuticals, 2021, 52(1):143-146.
[17]	国务院办公厅. 国务院办公厅关于印发药品上市许可持有人制度试点方案的通知. 中华人民共和国国务院公报, 2016(18):32-35.
	General Office of the State Council of the People’s Republic of China. General Office of the State Council of the People’s Republic of China Council on issuing the pilot program for the drug marketing authorization holder system. Gazette of the State Council of the People’s Republic of China, 2016(18):32-35.
[18]	赵阳, 袁鹏, 王兰明. 医疗器械注册人制度试点工作概况及相关思考. 中国食品药品监管, 2021(7):10-17.
	Zhao Y, Yuan P, Wang L M. Overview of the pilot program of medical device MAH system and relevant considerations. China Food & Drug Administration Magazine, 2021(7):10-17.
[19]	尹然. 浅析费用减缴办法的修改及影响. 中国发明与专利, 2019, 16(1):69-73.
	Yin R. Analysis on the amendment and influence of patent cost subtraction. China Invention & Patent, 2019, 16(1):69-73.
[20]	金婷, 王贺. 有关未盈利生物医药企业在香港及内地上市要求之比较. 法制与社会, 2018(13):78-79.
	Jin T, Wang H. Comparison of requirements for listing of unprofitable biopharmaceutical companies in Hong Kong and the Mainland. Legal System and Society, 2018(13):78-79.
[21]	郑建. 未盈利也可上市!科创板实施意见正式发布. 中国石油和化工, 2019(2):76.
	Zheng J. No profit can also be listed! Guidelines on the implementation of SSE STAR Market were released. China Petroleum and Chemical Industry, 2019(2):76.
[22]	陈俐, 冯楚健, 陈荣, 等. 英国促进科技成果转移转化的经验借鉴:以国家技术创新中心和高校产学研创新体系为例. 科技进步与对策, 2016, 33(15):9-14.
	Chen L, Feng C J, Chen R, et al. Experience reference of UK’s promoting sci-tech achievements transfer and transformation:take national technology innovation centre and industry-university-research innovation system as example. Science & Technology Progress and Policy, 2016, 33(15):9-14.
[23]	陈光华, 刘玉强, 靳宗振. 高技术研究机构与衍生企业关系研究. 科技进步与对策, 2017, 34(6):110-116.
	Chen G H, Liu Y Q, Jin Z Z. Relationship study on high-tech research institute and its spin-off enterprises. Science & Technology Progress and Policy, 2017, 34(6):110-116.
[24]	吴寿仁. 科技成果转移转化系列案例解析(四):上海交通大学科技成果转移转化案例分析. 科技中国, 2020(4):63-68.
	Wu S R. Case study on transformation of scientific and technological achievements (IV):case study on the technological achievements transformation in Shanghai Jiao Tong University. China Scitechnology Think Tank, 2020(4):63-68.
[25]	张锦源, 赵颖, 任春娟, 等. 某大型综合医院科技成果转化现状. 解放军医院管理杂志, 2020, 27(3):290-293.
	Zhang J Y, Zhao Y, Ren C J, et al. State quo of the technological achievements transformation in a large-scale comprehensive hospital. Hospital Administration Journal of Chinese PLA, 2020, 27(3):290-293.
[26]	罗欣, 吴东, 赵潺, 等. 推动医学青年创新的探索与实践. 中华医学科研管理杂志, 2020, 33(3):183-186.
	Luo X, Wu D, Zhao C, et al. Promoting the exploration and practice of medical youth innovation. Chinese Journal of Medical Science Research Management, 2020, 33(3):183-186.
[27]	姜雪, 何培欣, 刘一逸, 等. 临床医院科技成果转化的探索与实践:以北京大学第三医院为例. 中华医学科研管理杂志, 2020, 33(5):358-363.
	Jiang X, He P X, Liu Y Y, et al. Study on the mechanisms and practice of technology transfer in clinical hospitals: Take Peking University Third Hospital as an example. Chinese Journal of Medical Science Research Management, 2020, 33(5):358-363.
[28]	朱修篁, 易香华, 薛芳芳, 等. 生物医药专利分布及趋势研究. 中国新药杂志, 2015, 24(15):1686-1693.
	Zhu X H, Yi X H, Xue F F, et al. Investigation and analysis of healthcare patents distribution and trend. Chinese Journal of New Drugs, 2015, 24(15):1686-1693.
[29]	中国科技评估与成果管理研究会, 国家科技评估中心, 中国科学技术信息研究所. 中国科技成果转化2019年度报告(高等院校与科研院所篇). 北京: 科学技术文献出版社, 2020:9-14.
	China Association of Science and Technology Evaluation and Management of Scientific and Technical Achievement, National Center for Science & Technology Evaluation, Institute of Scientific and Technical Information of China. The annual report on the transformation of scientic and technological achievements in China 2019 (universities and research institutes). Beijing: Scientific and Technical Documents Publishing House, 2020:9-14.
[30]	王建峰, 张琳. 高校附属医院成果转化影响因素调查. 解放军医院管理杂志, 2018, 25(7):624-627.
	Wang J F, Zhang L. Investigation on impacts of achievement transformation of affiliated hospitals of universities and potential solutions. Hospital Administration Journal of Chinese PLA, 2018, 25(7):624-627.

[1]	陈莹,李谦. 特殊酵母工业应用专利发展态势分析[J]. 中国生物工程杂志, 2021, 41(4): 91-99.
[2]	吴函蓉,王莹,黄英明,李冬雪,李治非,方子寒,范玲. 以基地平台为抓手,促进生物技术创新与转化[J]. 中国生物工程杂志, 2021, 41(12): 141-147.
[3]	张正燕,陈钰,宋丽杰,苏政权,张海燕. 场效应晶体管生物传感器在生物医学检测中的应用研究进展^*[J]. 中国生物工程杂志, 2021, 41(10): 73-88.
[4]	曹萌,赵宇豪,郭中平. 从国际非专利名称纵观全球生物药发展[J]. 中国生物工程杂志, 2020, 40(1-2): 154-165.
[5]	蒋甜,张超,刘会洲. 微生物燃料电池发展态势分析[J]. 中国生物工程杂志, 2020, 40(1-2): 189-197.
[6]	谢华玲,吕璐成,杨艳萍. 全球冠状病毒疫苗专利分析[J]. 中国生物工程杂志, 2020, 40(1-2): 57-64.
[7]	赵萍,杨艳萍. 人冠状病毒感染诊断技术专利态势分析[J]. 中国生物工程杂志, 2020, 40(1-2): 51-56.
[8]	李东巧,吕璐成,杨艳萍. 全球人冠状病毒抗体领域研发现状与发展趋势[J]. 中国生物工程杂志, 2020, 40(1-2): 65-70.
[9]	黄鹏飞,陈赟,陆娇,毛开云,袁银池. *生物医药专利密集型产业发展现状及建议^——以上海市为例**[J]. 中国生物工程杂志, 2020, 40(12): 108-116.
[10]	赵建民,张思源. 耐药菌感染的噬菌体治疗专利技术[J]. 中国生物工程杂志, 2020, 40(10): 104-111.
[11]	任静,邹婉侬,宋敏. 跨国种业公司并购形成的国际种业竞争新格局变化趋势研究——以知识产权为例 ^*[J]. 中国生物工程杂志, 2019, 39(7): 108-117.
[12]	谢华玲,李东巧,迟培娟,杨艳萍. 合成生物学领域专利竞争态势分析[J]. 中国生物工程杂志, 2019, 39(4): 114-123.
[13]	王友华,邹婉侬,柳小庆,王兆华,孙国庆. 全球转基因玉米专利信息分析与技术展望 ^*[J]. 中国生物工程杂志, 2019, 39(12): 83-94.
[14]	范月蕾,陆娇,陈大明,毛开云. 干细胞专利价值评估与转移转化对策研究 ^*[J]. 中国生物工程杂志, 2019, 39(1): 99-106.
[15]	王方旭,陈玉玲,耿读艳,陈传芳. 趋磁细菌及磁小体的生物医学应用研究进展 ^*[J]. 中国生物工程杂志, 2018, 38(9): 74-80.

Viewed

Full text

Abstract

Cited

Shared

Discussed